Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART).
Shiga University of Medical Science, Seta, Otsu, Japan.
Uzu
Takashi
T
Sawaguchi
Makoto
M
Maegawa
Hiroshi
H
Kashiwagi
Atsunori
A
D000419:Albuminuria / Q000517:prevention & control*; D017311:Amlodipine / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068756:Valsartan
D000959:Antihypertensive Agents; D013777:Tetrazoles; D017311:Amlodipine; D000068756:Valsartan; D014633:Valine